Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (3)
  • 2022 (3)
  • 2021 (3)
  • 2020 (2)
  • 2019 (1)
  • 2017 (2)

Subject

  • Drug Trafficking (4016)
  • Synthetic drugs (1067)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (243)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Intelligence Division - Intelligence Products (5)

Drug Name

  • Opioids (4)
  • Cocaine (3)
  • Fentanyl (2)
  • Heroin (2)
  • Methamphetamine (2)
  • Oxycodone (2)
  • Synthetic Opioids (2)
  • Benzodiazepines (1)
  • Hydromorphone (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Morphine (1)

Field Division

  • Washington, DC (6)
  • Detroit (1)
  • Miami (1)
  • New England (1)
  • New Orleans (1)
  • Philadelphia (1)
  • Phoenix (1)
  • Rocky Mountain (1)
  • Sede (1)
Clear All Results
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

Mayo 15, 2025
WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...
Mayo 15, 2025
PRESS RELEASE

India-Based Chemical Company and Top Employees Indicted for Unlawful Import of Fentanyl Precursor Chemicals

Marzo 21, 2025
An India-based chemical manufacturing company and three high-level employees were charged in federal court in Washington, D.C., today related to illegally importing precursor chemicals used to make illicit fentanyl. According to the indictment, Vasudha Pharma Chem Limited (VPC), VPC Chief Global Business Officer Tanweer Ahmed Mohamed Hussain Parkar, 63, of...
Marzo 21, 2025
PRESS RELEASE

DEA Rocky Mountain Field Division Executes Search Warrant on Known Tren de Aragua Gang Location in Metro Denver

Enero 26, 2025
DENVER – The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) – in conjunction with federal and local partners – executed a federal search warrant on 6600 Federal Boulevard in Adams County, Colorado just before 5 a.m. MT today. Based on months-long investigative work, it was determined this makeshift nightclub...
Enero 26, 2025
PRESS RELEASE

DEA Graduates the Sixth Annual Citizens Academy Class in Richmond, Virginia

Julio 29, 2022
Richmond, Va., – The United States Drug Enforcement Administration is active in many local communities through Operation Engage, a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations, and collaboration with local partners. As part of this mission, Citizens Academies are held to connect field offices...
Julio 29, 2022
PRESS RELEASE

DEA Launches Second Year of Operation Engage

Marzo 23, 2022
PHOENIX – The United States Drug Enforcement Administration (DEA) Special Agent in Charge (SAC) Cheri Oz is pleased to announce the launching of the second year of Operation Engage, a comprehensive community-level approach to address the drug epidemic through prevention strategies, facilitating conversations and collaboration with local partners. “DEA’s priority...
Marzo 23, 2022
PRESS RELEASE

DEA Serves Immediate Suspension Order on Northgate Pharmacy in Waldorf, Maryland

Enero 27, 2022
Washington, D.C., - Jarod Forget, Special Agent in Charge of the DEA Washington Division, announced the issuance of an Immediate Suspension Order (ISO) at Northgate Pharmacy, located at 3973 Saint Charles Parkway, Waldorf, Maryland, today. This morning, members of the Drug Enforcement Administration (DEA) Washington Division’s Tactical Diversion Squad, along...
Enero 27, 2022
PRESS RELEASE

Charlottesville Dermatologist Sentenced for Diverting Pain Medication

Julio 30, 2021
CHARLOTTESVILLE, Va., – A dermatologist formerly employed at a dermatological practice in the City of Charlottesville was sentenced last week to 12 months probation, including a period of home confinement and electronic monitoring, for using the Drug Enforcement Administration (DEA) registration number of her co-workers to obtain prescription opioid pain...
Julio 30, 2021
PRESS RELEASE

North Carolina Man Pleads Guilty to Conspiring to Distribute Suboxone, Oxycodone, other Pain Medications

Julio 29, 2021
ABINGDON, Va., – A Dobson, North Carolina man pleaded guilty yesterday to conspiring to distribute medically illegitimate prescriptions for Schedule II opioids and Suboxone, as well as conspiring to use, in the course of the distribution of controlled substances, the DEA registration number of another person. According to court documents...
Julio 29, 2021
PRESS RELEASE

DEA Washington Division Releases 2020 National Drug Threat Assessment for D.C., Maryland, and Virginia Communities

Marzo 02, 2021
Washington, D.C. – Today, DEA Acting Administrator D. Christopher Evans, and Special Agent in Charge of the DEA Washington Division, Jarod Forget, announce the release of the 2020 National Drug Threat Assessment – DEA’s annual publication outlining the threats posed to the U.S. by domestic and international drug trafficking and...
Marzo 02, 2021
PRESS RELEASE

DEA Announces 360 Strategy to address substance use disorder, Fentanyl, Heroin, Presciption Misuse, and Violent Crime in Maine

Diciembre 01, 2020
PORTLAND, ME – DEA New England Division Special Agent in Charge Brian D. Boyle announced today that Maine will be the 19 th site where DEA will implement its comprehensive DEA 360 Strategy initiative to address prescription misuse, poly substance misuse and violent crime. DEA 360 Strategy is a comprehensive...
Diciembre 01, 2020
Showing 1 - 10 of 14 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster